As of April 10, 2024, the company has received $158,000,000 in its first tranche. The transaction was led by returning investor Deep Track Capital, LP. The transaction included participation from new investors RA Capital Management, L.P., Avidity Partners Management, L.P., returning investors UC Investments, Blue Owl Healthcare Opportunities, Perceptive Advisors LLC, Goldman Sachs Asset Management, L.P., Bristol-Myers Squibb Company, Vertex Ventures HC, Moore Strategic Ventures, LLC, Perceptive Xontogeny Venture Fund, LP.

and other institutional backers. The company raised greater than $350,000,000 in funding till date. The transaction was oversubscribed.